Cardiovascular magnetic resonance (CMR) is a comprehensive noninvasive diagnostic tool for cardiac conditions. Factors affecting CMR efficiency include image acquisition, analysis, patient compliance, scan times, scanner accessibility, and expert personnel availability. This project aimed to optimize image acquisition time and diagnostic accuracy in CMR by in-person and remote real-time supervision of pathology-driven scan protocols tailored to the most likely clinical diagnosis. A review of 343 contrast and noncontrast CMR scans revealed a statistically significant 35.1% decrease in average scan duration from preintervention to postintervention, from 94.78 to 61.49 minutes, with improved diagnostic accuracy. This decrease directly resulted in an increase in CMR scan volume of 32% at the main campus and 200% at a satellite campus, as well as the establishment of a new CMR imaging service line at a third satellite campus. Streamlining CMR workflow improves efficiency, patient access, and diagnostic accuracy, leading to better patient outcomes.
Coronary computed tomography angiography (CCTA) is an American Heart Association/American College of Cardiology Class Ia diagnostic test for chest pain evaluation, but radiation exposure limits its use. By applying the Nuclear Regulatory Commission's "as low as reasonably achievable" principle and streamlining workflows using patient-specific scanning protocols, radiation dose can be reduced without sacrificing diagnostic accuracy. At The University of Texas Medical Branch satellite campus, we implemented standardized patient-specific computed tomography (CT) scanner protocols with a goal of reducing patient radiation and improving image quality. Comparison of pre- and postintervention scans from 146 patients revealed that the median radiation dose decreased by 63.4% (19.4 vs 7.1 mSv; P < 0.0001), with a greater decrease in women and a higher body mass index-to-dose correlation after intervention. Standardized, patient-specific protocols for CCTA substantially reduce radiation dose. Implementing effective interventions requires understanding CT scanner capabilities, using vendor support, and maintaining consistent feedback loops between the imaging physician and the CT technologist.
Hypertrophic cardiomyopathy (HCM) and cardiac amyloidosis (CA) are key differential diagnoses in patients presenting with an increase in left ventricular wall thickness. Despite advances in multimodal imaging, both conditions remain underrecognized due to overlapping morphological and clinical features that complicate diagnosis and treatment. However, their distinct pathophysiological mechanisms—myocardial hypertrophy and myofibrillar disarray in HCM versus extracellular deposition of misfolded amyloid protein in CA—have direct implications for management. Timely and accurate diagnosis is critical to optimizing patient care and preventing serious adverse outcomes, including sudden cardiac death. Epidemiological factors such as age, sex, and geographic distribution, along with specific clinical characteristics, can increase pretest probability and guide targeted diagnostic evaluation. As we enter a new era of precision medicine, this review comprehensively discusses the epidemiological, clinical, and imaging distinctions between HCM and CA to enhance diagnostic accuracy and clinician awareness to provide optimal care delivery.